- CA$171.49m
- CA$168.51m
- CA$14.03m
- 46
- 93
- 70
- 80
Annual balance sheet for Premium Income, fiscal year end - October 31st, CAD millions except per share, conversion factor applied.
2021 October 31st | 2022 October 31st | 2023 October 31st | 2024 October 31st | 2025 October 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Short Term Investments | 3.4 | 2.56 | 3.46 | 0.026 | 2.98 |
| Net Total Receivables | 1.16 | 1.36 | 1.53 | 2 | 1.74 |
| Long Term Investments | |||||
| Total Other Assets | |||||
| Total Assets | 303 | 257 | 237 | 397 | 423 |
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Other Current Liabilities | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 6.2 | 0.314 | 0.363 | 0.332 | 4.37 |
| Redeemable Preferred Stock | |||||
| Common Stock | |||||
| Total Equity | 297 | 257 | 237 | 397 | 419 |
| Total Liabilities & Shareholders' Equity | 303 | 257 | 237 | 397 | 423 |
| Total Common Shares Outstanding | |||||
| Total Preferred Shares Outstanding |